Nexsen (FRA:WG0) Graham Number: €N/A (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WG0 Nexsen Ltd FRA:WG0
7 GF Score
Price €0.10
! 1 Warning Sign
View Full Analysis

What is Nexsen Graham Number?

Nexsen FRA:WG0 +3.21% 7 Graham Number is €N/A as of Dec. 2025. GuruFocus rates FRA:WG0 with a GF Score™ of 7/100. The stock has 1 warning sign investors should review. Among 259 Biotechnology companies, Nexsen ranks worse than 386100% on this metric.

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2026-09-10), the stock price of Nexsen is €0.103. Nexsen's graham number for the quarter that ended in Dec. 2025 was €N/A. Therefore, Nexsen's Price to Graham Number ratio for today is N/A.

The historical rank and industry rank for Nexsen's Graham Number or its related term are showing as below:

FRA:WG0's Price-to-Graham-Number is not ranked *
in the Biotechnology industry.
Industry Median: 1.84
* Ranked among companies with meaningful Price-to-Graham-Number only.

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Nexsen  (FRA:WG0) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Nexsen's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Dec. 2025 )
=0.103/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Nexsen Graham Number Related Terms


Nexsen Graham Number Historical Data

* Premium members only.

The historical data trend for Nexsen's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexsen Graham Number Chart

Nexsen Annual Data
Trend Jun23 Jun24 Jun25 Jun26
Graham Number
0.00 0.00 0.00 0.00

Nexsen Semi-Annual Data
Jun23 Jun24 Jun25 Dec25 Jun26
Graham Number 0.00 0.00 0.00 0.00 0.00

FRA:WG0 vs VRTX, REGN, MRNA: Graham Number Comparison

For the Biotechnology subindustry, Nexsen's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nexsen Price-to-Graham-Number vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nexsen's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Nexsen's Price-to-Graham-Number falls into.


FRA:WG0
7GF Score
Nexsen Ltd FRA:WG0
Graham Number is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexsen Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Nexsen's Graham Number for the fiscal year that ended in Jun. 2025 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*-0.006*-0.014)
=N/A

Nexsen's Graham Number for the quarter that ended in Dec. 2025 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*0.017*-0.021)
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Graham Number →
What does a Graham Number of €N/A mean?
Nexsen (FRA:WG0) has a Graham Number of €N/A as of Dec. 2025. The Graham Number values a company based on its per-share earnings and book value. View historical data on Nexsen and its competitors. According to the industry distribution chart, Nexsen ranks #999999 out of 259 companies in the Biotechnology industry.
Is Nexsen's Graham Number too high?
Nexsen's current Graham Number is €N/A. Based on the distribution chart, Nexsen ranks #999999 out of 259 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nexsen has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Nexsen's Graham Number compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nexsen ranks #999999 out of 259 companies for Graham Number. This places Nexsen in the lower half of its industry. The industry median Graham Number is 1.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Biotechnology company?
The median Graham Number among Biotechnology companies is 1.84, based on 259 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Nexsen and its competitors. For the Biotechnology industry, the median Graham Number is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexsen's current Graham Number is €N/A. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexsen stock overvalued right now?
Nexsen (FRA:WG0) has a current Graham Number of €N/A. The current Graham Number is €N/A. Nexsen's overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Nexsen (FRA:WG0), the current Graham Number is €N/A as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexsen Business Description

Other Exchanges NXN:Australia
Address 4 Bridge Street, Suite 1005, Sydney, NSW, AUS, 2000
Nexsen Ltd is a nanobiotechnology company for the development of biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural and biosecurity applications. Its products include: GBS Rapid Sensor, Chronic Kidney Disease (CKD), Bovine Mastitis, Acute Kidney Injury (AKI), and Biosecurity Pathogen Tests (x2).
7GF Score

Get the complete analysis for FRA:WG0

Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price